Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchSelect treatment..Select..
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

 

Changes in memory and cognition during the SARS-CoV-2 human challenge study

Trender et al., eClinicalMedicine, doi:10.1016/j.eclinm.2024.102842, NCT04865237
Sep 2024  
  Post
  Facebook
Share
  Source   PDF  
Human challenge study inoculating 34 patients with SARS-CoV-2 and showing significantly lower cognitive scores in infected patients that persisted for at least a year. The differences were greatest for memory and executive functions.
Results suggest that even mild COVID-19 cases can result in persistent cognitive deficits, highlighting the importance of preventing viral replication from progressing to other tissues including the nervous system.
Results show a significant increase in GFAP levels 14 days post-inoculation in SARS-CoV-2-infected individuals, suggesting mild COVID-19 infection may lead to astrocytic activation and potential brain injury. GFAP (Glial Fibrillary Acidic Protein) is predominantly found in astrocytes, cells in the central nervous system that support and protect neurons, maintain the blood-brain barrier, and regulate ion balance. Elevated GFAP levels are associated with neurological diseases and injuries, including Alzheimer's disease, multiple sclerosis, and traumatic brain injury.
Researchers left most patients untreated except for six patients assigned to pre-emptive remdesivir. Studies point to the nasal respiratory epithelium as the primary source of infection and initial replication, and studies of several nasopharyngeal/oropharyngeal treatments show that targeted treatment to the source of initial infection can minimize progression.
Trender et al., 21 Sep 2024, retrospective, United Kingdom, peer-reviewed, mean age 22.3, 12 authors, study period 6 March, 2021 - 8 July, 2021, trial NCT04865237 (history). Contact: adam.hampshire@kcl.ac.uk.
This PaperMiscellaneousAll
Changes in memory and cognition during the SARS-CoV-2 human challenge study
William Trender, Peter J Hellyer, Ben Killingley, Mariya Kalinova, Alex J Mann, Andrew P Catchpole, David Menon, Edward Needham, Ryan Thwaites, Christopher Chiu, Gregory Scott, Adam Hampshire
eClinicalMedicine, doi:10.1016/j.eclinm.2024.102842
Background Patient-reported outcomes and cross-sectional evidence show an association between COVID-19 and persistent cognitive problems. The causal basis, longevity and domain specificity of this association is unclear due to population variability in baseline cognitive abilities, vulnerabilities, virus variants, vaccination status and treatment. Methods Thirty-four young, healthy, seronegative volunteers were inoculated with Wildtype SARS-CoV-2 under prospectively controlled conditions. Volunteers completed daily physiological measurements and computerised cognitive tasks during quarantine and follow-up at 30, 90, 180, 270, and 360 days. Linear modelling examined differences between 'infected' and 'inoculated but uninfected' individuals. The main cognitive endpoint was the baseline corrected global cognitive composite score across the battery of tasks administered to the volunteers. Exploratory cognitive endpoints included baseline corrected scores from individual tasks. The study was registered on ClinicalTrials.gov with the identifier NCT04865237 and took place between March 2021 and July 2022. Findings Eighteen volunteers developed infection by qPCR criteria of sustained viral load, one without symptoms and the remainder with mild illness. Infected volunteers showed statistically lower baseline-corrected global composite cognitive scores than uninfected volunteers, both acutely and during follow up (mean difference over all time points = -0.8631, 95% CI = -1.3613, -0.3766) with significant main effect of group in repeated measures ANOVA (F (1,34) = 7.58, p = 0.009). Sensitivity analysis replicated this cross-group difference after controlling for community upper respiratory tract infection, task-learning, remdesivir treatment, baseline reference and model structure. Memory and executive function tasks showed the largest between-group differences. No volunteers reported persistent subjective cognitive symptoms. Interpretation These results support larger cross sectional findings indicating that mild Wildtype SARS-CoV-2 infection can be followed by small changes in cognition and memory that persist for at least a year. The mechanistic basis and clinical implications of these small changes remain unclear.
Appendix A. Supplementary data Supplementary data related to this article can be found at https://doi. org/10.1016/j.eclinm.2024.102842.
References
Amalakanti, Arepalli, Jillella, Cognitive assessment in asymptomatic COVID-19 subjects, VirusDisease
Becker, Vannorsdall, Weisenbach, Evaluation of post-COVID-19 cognitive dysfunction: recommendations for researchers, JAMA Psychiatr, doi:10.1001/jamapsychiatry.2023.2820
Bland, Barraclough, Trender, Profiles of objective and subjective cognitive function in Post-COVID Syndrome, COVID-19 recovered, and COVID-19 naïve individuals, Sci Rep
Brutto, Rumbea, Recalde, Mera, Cognitive sequelae of long COVID may not be permanent: a prospective study, Eur J Neurol
Brutto, Wu, Mera, Costa, Recalde et al., Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: a longitudinal prospective study nested to a population cohort, Eur J Neurol
Burden, Long, Collaborators, Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021, JAMA
Cheetham, Penfold, Giunchiglia, The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort study, eCli-nicalMedicine, doi:10.1016/j.eclinm.2023.102086
Douaud, Lee, Alfaro-Almagro, SARS-CoV-2 is associated with changes in brain structure in UK Biobank, Nature
Drefahl, Wallace, Mussino, A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden, Nat Commun
Ellingjord-Dale, Brunvoll, Søraas, Prospective memory assessment before and after Covid-19, N Engl J Med
Ellul, Varatharaj, Nicholson, Defining causality in COVID-19 and neurological disorders, J Neurol Neurosurg Psychiatry
Evans, Mcauley, Harrison, Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study, Lancet Respir Med
França, Bitencourt, Maximilla, Barros, Monserrat, Hippocampal neurogenesis and pattern separation: a meta-analysis of behavioral data, Hippocampus
Frontera, Boutajangout, Masurkar, Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia, Alzheimers Dement
Godoy-González, Ventura, Gomà, Objective and subjective cognition in survivors of COVID-19 one year after ICU discharge: the role of demographic, clinical, and emotional factors, Crit Care
Hampshire, Azor, Atchison, Cognition and memory after covid-19 in a large community sample, N Engl J Med
Hampshire, Chatfield, Mphil, Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort, eClinicalMedicine
Hampshire, Highfield, Parkin, Owen, Fractionating human intelligence, Neuron
Hampshire, Trender, Chamberlain, Cognitive deficits in people who have recovered from COVID-19, eClinicalMedicine, doi:10.1016/j.eclinm.2021.101044
Killingley, Mann, Kalinova, Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults, Nat Med
Lan, Filler, Mathew, Sociodemographic risk factors for coronavirus disease 2019 (COVID-19) infection among Massachusetts healthcare workers: a retrospective cohort study, Infect Control Hosp Epidemiol
Liu, Chen, Wang, One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study, JAMA Neurol
Miskowiak, Pedersen, Gunnarsson, Cognitive impairments among patients in a long-COVID clinic: prevalence, pattern and relation to illness severity, work function and quality of life, J Affect Disord
Needham, Ren, Digby, Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses, Brain
Pihlaja, Kauhanen, Ollila, Associations of subjective and objective cognitive functioning after COVID-19: a sixmonth follow-up of ICU, ward, and home-isolated patients, Brain Behav Immun Health
Rapeport, Smith, Gilbert, Catchpole, Mcshane et al., SARS-CoV-2 human challenge studiesestablishing the model during an evolving pandemic, N Engl J Med
Smith, Twenty-five years of research on the behavioural malaise associated with influenza and the common cold, Psychoneuroendocrinology
Soreq, Leech, Hampshire, Dynamic network coding of working-memory domains and working-memory processes, Nat Commun
Taquet, Skorniewska, Hampshire, Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization, Nat Med
Zhao, Shibata, Hellyer, Rapid vigilance and episodic memory decrements in COVID-19 survivors, Brain Commun
Zhou, Lu, Chen, The landscape of cognitive function in recovered COVID-19 patients, J Psychiatr Res
{ 'indexed': {'date-parts': [[2024, 9, 21]], 'date-time': '2024-09-21T18:10:15Z', 'timestamp': 1726942215650}, 'reference-count': 31, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2024, 10, 1]], 'date-time': '2024-10-01T00:00:00Z', 'timestamp': 1727740800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2024, 10, 1]], 'date-time': '2024-10-01T00:00:00Z', 'timestamp': 1727740800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/legal/tdmrep-license'}, { 'start': { 'date-parts': [[2024, 9, 5]], 'date-time': '2024-09-05T00:00:00Z', 'timestamp': 1725494400000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by/4.0/'}], 'content-domain': { 'domain': ['thelancet.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2024, 10]]}, 'DOI': '10.1016/j.eclinm.2024.102842', 'type': 'journal-article', 'created': {'date-parts': [[2024, 9, 21]], 'date-time': '2024-09-21T17:31:23Z', 'timestamp': 1726939883000}, 'page': '102842', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'special_numbering': 'C', 'title': 'Changes in memory and cognition during the SARS-CoV-2 human challenge study', 'prefix': '10.1016', 'volume': '76', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-3947-5532', 'authenticated-orcid': False, 'given': 'William', 'family': 'Trender', 'sequence': 'first', 'affiliation': []}, {'given': 'Peter J.', 'family': 'Hellyer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ben', 'family': 'Killingley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mariya', 'family': 'Kalinova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alex J.', 'family': 'Mann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew P.', 'family': 'Catchpole', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Menon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Edward', 'family': 'Needham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ryan', 'family': 'Thwaites', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher', 'family': 'Chiu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gregory', 'family': 'Scott', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-5176-5420', 'authenticated-orcid': False, 'given': 'Adam', 'family': 'Hampshire', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.eclinm.2024.102842_bib1', 'doi-asserted-by': 'crossref', 'first-page': '1604', 'DOI': '10.1001/jama.2022.18931', 'article-title': 'Estimated global proportions of individuals with persistent fatigue, ' 'cognitive, and respiratory symptom clusters following symptomatic ' 'COVID-19 in 2020 and 2021', 'volume': '328', 'year': '2022', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.eclinm.2024.102842_bib2', 'article-title': 'Cognitive deficits in people who have recovered from COVID-19', 'volume': '0', 'author': 'Hampshire', 'year': '2021', 'journal-title': 'eClinicalMedicine'}, { 'key': '10.1016/j.eclinm.2024.102842_bib3', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.eclinm.2022.101417', 'article-title': 'Multivariate profile and acute-phase correlates of cognitive deficits ' 'in a COVID-19 hospitalised cohort', 'volume': '47', 'author': 'Hampshire', 'year': '2022', 'journal-title': 'eClinicalMedicine'}, { 'key': '10.1016/j.eclinm.2024.102842_bib4', 'doi-asserted-by': 'crossref', 'first-page': '98', 'DOI': '10.1016/j.jpsychires.2020.06.022', 'article-title': 'The landscape of cognitive function in recovered COVID-19 patients', 'volume': '129', 'author': 'Zhou', 'year': '2020', 'journal-title': 'J\xa0Psychiatr Res'}, { 'key': '10.1016/j.eclinm.2024.102842_bib5', 'doi-asserted-by': 'crossref', 'first-page': '1275', 'DOI': '10.1016/S2213-2600(21)00383-0', 'article-title': 'Physical, cognitive, and mental health impacts of COVID-19 after ' 'hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort ' 'study', 'volume': '9', 'author': 'Evans', 'year': '2021', 'journal-title': 'Lancet Respir Med'}, { 'key': '10.1016/j.eclinm.2024.102842_bib6', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/braincomms/fcab295', 'article-title': 'Rapid vigilance and episodic memory decrements in COVID-19 survivors', 'volume': '4', 'author': 'Zhao', 'year': '2022', 'journal-title': 'Brain Commun'}, { 'key': '10.1016/j.eclinm.2024.102842_bib7', 'doi-asserted-by': 'crossref', 'first-page': '146', 'DOI': '10.1007/s13337-021-00663-w', 'article-title': 'Cognitive assessment in asymptomatic COVID-19 subjects', 'volume': '32', 'author': 'Amalakanti', 'year': '2021', 'journal-title': 'VirusDisease'}, { 'key': '10.1016/j.eclinm.2024.102842_bib8', 'doi-asserted-by': 'crossref', 'first-page': '509', 'DOI': '10.1001/jamaneurol.2022.0461', 'article-title': 'One-year trajectory of cognitive changes in older survivors of COVID-19 ' 'in Wuhan, China: a longitudinal cohort study', 'volume': '79', 'author': 'Liu', 'year': '2022', 'journal-title': 'JAMA Neurol'}, { 'key': '10.1016/j.eclinm.2024.102842_bib9', 'doi-asserted-by': 'crossref', 'first-page': '1218', 'DOI': '10.1111/ene.15215', 'article-title': 'Cognitive sequelae of long COVID may not be permanent: a prospective ' 'study', 'volume': '29', 'author': 'Del Brutto', 'year': '2022', 'journal-title': 'Eur J Neurol'}, { 'key': '10.1016/j.eclinm.2024.102842_bib10', 'article-title': 'Associations of subjective and objective cognitive functioning after ' 'COVID-19: a six-month follow-up of ICU, ward, and home-isolated ' 'patients', 'volume': '27', 'author': 'Pihlaja', 'year': '2023', 'journal-title': 'Brain Behav Immun Health'}, { 'key': '10.1016/j.eclinm.2024.102842_bib11', 'doi-asserted-by': 'crossref', 'first-page': '806', 'DOI': '10.1056/NEJMoa2311330', 'article-title': 'Cognition and memory after covid-19 in a large community sample', 'volume': '390', 'author': 'Hampshire', 'year': '2024', 'journal-title': 'N\xa0Engl J Med'}, { 'key': '10.1016/j.eclinm.2024.102842_bib12', 'doi-asserted-by': 'crossref', 'first-page': '3245', 'DOI': '10.1111/ene.14775', 'article-title': 'Cognitive decline among individuals with history of mild symptomatic ' 'SARS-CoV-2 infection: a longitudinal prospective study nested to a ' 'population cohort', 'volume': '28', 'author': 'Del Brutto', 'year': '2021', 'journal-title': 'Eur J Neurol'}, { 'key': '10.1016/j.eclinm.2024.102842_bib13', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.eclinm.2023.102086', 'article-title': 'The effects of COVID-19 on cognitive performance in a community-based ' 'cohort: a COVID symptom study biobank prospective cohort study', 'volume': '62', 'author': 'Cheetham', 'year': '2023', 'journal-title': 'eClinicalMedicine'}, { 'key': '10.1016/j.eclinm.2024.102842_bib14', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1038/s41586-022-04569-5', 'article-title': 'SARS-CoV-2 is associated with changes in brain structure in UK Biobank', 'volume': '604', 'author': 'Douaud', 'year': '2022', 'journal-title': 'Nature'}, { 'key': '10.1016/j.eclinm.2024.102842_bib15', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/brain/awac321', 'article-title': 'Brain injury in COVID-19 is associated with dysregulated innate and ' 'adaptive immune responses', 'volume': '145', 'author': 'Needham', 'year': '2022', 'journal-title': 'Brain'}, { 'key': '10.1016/j.eclinm.2024.102842_bib16', 'doi-asserted-by': 'crossref', 'first-page': '899', 'DOI': '10.1002/alz.12556', 'article-title': 'Comparison of serum neurodegenerative biomarkers among hospitalized ' 'COVID-19 patients versus non-COVID subjects with normal cognition, mild ' "cognitive impairment, or Alzheimer's dementia", 'volume': '18', 'author': 'Frontera', 'year': '2022', 'journal-title': 'Alzheimers Dement'}, { 'key': '10.1016/j.eclinm.2024.102842_bib17', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1038/s41591-023-02525-y', 'article-title': 'Acute blood biomarker profiles predict cognitive deficits 6 and 12 ' 'months after COVID-19 hospitalization', 'volume': '29', 'author': 'Taquet', 'year': '2023', 'journal-title': 'Nat Med'}, { 'key': '10.1016/j.eclinm.2024.102842_bib18', 'doi-asserted-by': 'crossref', 'first-page': '1473', 'DOI': '10.1017/ice.2021.17', 'article-title': 'Sociodemographic risk factors for coronavirus disease 2019 (COVID-19) ' 'infection among Massachusetts healthcare workers: a retrospective ' 'cohort study', 'volume': '42', 'author': 'Lan', 'year': '2021', 'journal-title': 'Infect Control Hosp Epidemiol'}, { 'key': '10.1016/j.eclinm.2024.102842_bib19', 'doi-asserted-by': 'crossref', 'first-page': '5097', 'DOI': '10.1038/s41467-020-18926-3', 'article-title': 'A\xa0population-based cohort study of socio-demographic risk factors ' 'for COVID-19 deaths in Sweden', 'volume': '11', 'author': 'Drefahl', 'year': '2020', 'journal-title': 'Nat Commun'}, { 'key': '10.1016/j.eclinm.2024.102842_bib20', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jamapsychiatry.2023.2820', 'article-title': 'Evaluation of post–COVID-19 cognitive dysfunction: recommendations for ' 'researchers', 'author': 'Becker', 'year': '2023', 'journal-title': 'JAMA Psychiatr'}, { 'key': '10.1016/j.eclinm.2024.102842_bib21', 'doi-asserted-by': 'crossref', 'first-page': '1031', 'DOI': '10.1038/s41591-022-01780-9', 'article-title': 'Safety, tolerability and viral kinetics during SARS-CoV-2 human ' 'challenge in young adults', 'volume': '28', 'author': 'Killingley', 'year': '2022', 'journal-title': 'Nat Med'}, { 'key': '10.1016/j.eclinm.2024.102842_bib22', 'doi-asserted-by': 'crossref', 'first-page': '936', 'DOI': '10.1038/s41467-019-08840-8', 'article-title': 'Dynamic network coding of working-memory domains and working-memory ' 'processes', 'volume': '10', 'author': 'Soreq', 'year': '2019', 'journal-title': 'Nat Commun'}, { 'key': '10.1016/j.eclinm.2024.102842_bib23', 'doi-asserted-by': 'crossref', 'first-page': '1225', 'DOI': '10.1016/j.neuron.2012.06.022', 'article-title': 'Fractionating human intelligence', 'volume': '76', 'author': 'Hampshire', 'year': '2012', 'journal-title': 'Neuron'}, { 'key': '10.1016/j.eclinm.2024.102842_bib24', 'doi-asserted-by': 'crossref', 'first-page': '961', 'DOI': '10.1056/NEJMp2106970', 'article-title': 'SARS-CoV-2 human challenge studies — establishing the model during an ' 'evolving pandemic', 'volume': '385', 'author': 'Rapeport', 'year': '2021', 'journal-title': 'N\xa0Engl J Med'}, { 'key': '10.1016/j.eclinm.2024.102842_bib25', 'doi-asserted-by': 'crossref', 'first-page': '811', 'DOI': '10.1136/jnnp-2020-323667', 'article-title': 'Defining causality in COVID-19 and neurological disorders', 'volume': '91', 'author': 'Ellul', 'year': '2020', 'journal-title': 'J\xa0Neurol Neurosurg Psychiatry'}, { 'key': '10.1016/j.eclinm.2024.102842_bib26', 'doi-asserted-by': 'crossref', 'first-page': '162', 'DOI': '10.1016/j.jad.2022.12.122', 'article-title': 'Cognitive impairments among patients in a long-COVID clinic: ' 'prevalence, pattern and relation to illness severity, work function and ' 'quality of life', 'volume': '324', 'author': 'Miskowiak', 'year': '2023', 'journal-title': 'J\xa0Affect Disord'}, { 'key': '10.1016/j.eclinm.2024.102842_bib27', 'doi-asserted-by': 'crossref', 'first-page': '937', 'DOI': '10.1002/hipo.22746', 'article-title': 'Hippocampal neurogenesis and pattern separation: a meta-analysis of ' 'behavioral data', 'volume': '27', 'author': 'França', 'year': '2017', 'journal-title': 'Hippocampus'}, { 'key': '10.1016/j.eclinm.2024.102842_bib28', 'doi-asserted-by': 'crossref', 'first-page': '863', 'DOI': '10.1056/NEJMc2311200', 'article-title': 'Prospective memory assessment before and after Covid-19', 'volume': '390', 'author': 'Ellingjord-Dale', 'year': '2024', 'journal-title': 'N\xa0Engl J Med'}, { 'key': '10.1016/j.eclinm.2024.102842_bib29', 'doi-asserted-by': 'crossref', 'first-page': '188', 'DOI': '10.1186/s13054-023-04478-7', 'article-title': 'Objective and subjective cognition in survivors of COVID-19 one year ' 'after ICU discharge: the role of demographic, clinical, and emotional ' 'factors', 'volume': '27', 'author': 'Godoy-González', 'year': '2023', 'journal-title': 'Crit Care'}, { 'key': '10.1016/j.eclinm.2024.102842_bib30', 'doi-asserted-by': 'crossref', 'DOI': '10.1038/s41598-024-62050-x', 'article-title': 'Profiles of objective and subjective cognitive function in Post-COVID ' 'Syndrome, COVID-19 recovered, and COVID-19 naïve individuals', 'volume': '14', 'author': 'Bland', 'year': '2024', 'journal-title': 'Sci Rep'}, { 'key': '10.1016/j.eclinm.2024.102842_bib31', 'doi-asserted-by': 'crossref', 'first-page': '744', 'DOI': '10.1016/j.psyneuen.2012.09.002', 'article-title': 'Twenty-five years of research on the behavioural malaise associated ' 'with influenza and the common cold', 'volume': '38', 'author': 'Smith', 'year': '2013', 'journal-title': 'Psychoneuroendocrinology'}], 'container-title': 'eClinicalMedicine', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S2589537024004218?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S2589537024004218?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2024, 9, 21]], 'date-time': '2024-09-21T17:31:29Z', 'timestamp': 1726939889000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S2589537024004218'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 10]]}, 'references-count': 31, 'alternative-id': ['S2589537024004218'], 'URL': 'http://dx.doi.org/10.1016/j.eclinm.2024.102842', 'relation': {}, 'ISSN': ['2589-5370'], 'subject': [], 'container-title-short': 'eClinicalMedicine', 'published': {'date-parts': [[2024, 10]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Changes in memory and cognition during the SARS-CoV-2 human challenge study', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'eClinicalMedicine', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.eclinm.2024.102842', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2024 The Authors. Published by Elsevier Ltd.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '102842'}
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit